Search ( 6822 results )
- article
(Updated on )
Residual risk of HIV, HCV, and HBV transmission through blood transfusion in France between 1992 and 2002 and the impact of viral genomic testing
Changes in the residual viral risk associated with labile blood products are an important indicator for assessing the impact of measures aimed at improving viral safety in blood...
- article
(Updated on )
Surveillance of Syphilis Among Blood Donors in Metropolitan France, 2009–2011
- article
(Updated on )
The risk of screening out anemic blood donors and the effectiveness of pre-donation hemoglobin testing in France in 2010
- article
(Updated on )
Quantitative estimation of the risk of blood donation contamination by infectious agents
The presence of asymptomatic shedding of certain infectious agents poses a risk of transmission during blood transfusion. While this risk is currently well controlled for certain...
- article
(Updated on )
The prevalence of viral markers among unpaid blood donors in Europe declined between 1990 and 1996. Eurosynthèse
In Europe, nonprofit plasma fractionation organizations believe that standardized epidemiological data collection and analysis is a key public health issue. These organizations are...
- article
(Updated on )
Assessing an emerging transfusion risk: the example of HEV
Objective: Transfusion risk assessment is an essential step that must precede any screening strategy for a transfusion-transmissible pathogen. Following the occurrence of several cases...
- article
(Updated on )
The Effectiveness of Blood Transfusion Safety Measures Regarding HTLV in 2014
In industrialized countries, at a time when the viral safety of blood products has reached an all-time high, and when efforts to control public spending regularly prompt discussions...
- article
(Updated on )
Seroprevalence of measles and rubella among young adult blood donors in France, 2013
As part of the evaluation of the French plan for the elimination of measles and rubella, we conducted a seroprevalence survey in 2013 to update seroprevalence data for people aged 18–32....
- article
(Updated on )
Type 2 diabetes in France: epidemiology, trends in the quality of care, and social and economic impact. Between 2007
In France between 2001 and 2007, treatment for type 2 diabetes became more intensive and therapeutic options improved. However, glycemic control remains inadequate. Management of...
